USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma
Our findings reveal that USP5 serve as a potential target for tumor intervention and provide a preliminary antitumor therapy for inhibit EMT by targeting USP5 or its interaction with SLUG in HCC.
